from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2374c/hrcA

LFCtreatmentdescriptionclass of inhibitor

0.334

Amikacinug/mL Amikacintranslation

1.555

Cap5-10ug/mL Capreomycintranslation

0.871

Rox10-50 ug/mL Roxithromycintranslation

-0.522

SM2-5 ug/mL Streptomycintranslation

1.783

Tet5-10 ug/mL Tetracyclinetranslation

-0.603

Rif0.2-5ug/mL Rifampicintranscription

0.022

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.051

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.898

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.155

CPZ10-50 ug/mL Chlorpromazinerespiration

0.762

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.157

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.774

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.612

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.381

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.272

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.220

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.384

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.441

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.847

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.551

KCN5-20 ug/mL Potassium cyaniderespiration

-0.375

NaN30.2-2 mM Sodium aziderespiration

0.732

Nigericin50 uM Nigericinrespiration

0.348

TRC10-150 ug/mL Triclosanrespiration

2.075

TRZ10-25 ug/mL Thioridazinerespiration

1.661

Valinomycin0.5-10 uM Valinomycinrespiration

-0.211

ZnSO42 mM ZnSO4respiration

0.729

menadione6-10 ug/mL Menadionerespiration

-0.121

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.616

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.430

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.702

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.356

NRP_1Non-replicating persistence stage 1dosRassociated

-0.910

Amp0.2mg/mL AmpicillincellWall

-0.501

Cephalexin20-100 ug/mL CephalexincellWall

0.329

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.477

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.651

EMB10-20 ug/mL EthambutolcellWall

-0.683

Eta12-40 ug/mL EthionamidecellWall

-0.798

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.328

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.709

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.790

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.426

BZA0.12 mg/mL BenzamidearomaticAmides

-0.483

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.369

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.389

H2O24 mM hydrogen peroxideDNAdamaging

0.106

Levo10 ug/mL LevofloxacinDNAdamaging

-0.515

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.932

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.674

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.831

UVUV-irradiationDNAdamaging

1.299

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.588

Antimycin12.5-50 ug/mL Antimycin A?

-0.233

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.191

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.966

PA8240.2-2 ug/mL PA-824?

0.718

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.079

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.110

Verapamil50 uM Verapamil?

-0.642

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.562

methoxatin10-20 ug/mL Methoxatin?